You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
金安國紀(002636.SZ)擬3億元投資新建全州中成藥生產基地
格隆匯 04-06 16:33

格隆匯 4 月 6日丨金安國紀(002636.SZ)公佈,公司於2021年4月6日召開了第四屆董事會第二十五次會議,審議通過了《金安國紀全州中成藥生產基地建設項目的議案》,同意公司在廣西省桂林市全州縣投資新建全州中成藥生產基地,該項目計劃投資總額為3億元人民幣。

公吿稱,該項目土地使用面積約110畝,分兩期建設。其中,項目一期計劃建築面積約5萬平方米,擬新設9條生產線及配套中藥提取。預計新增年銷售金額約4億元人民幣。項目二期擬新設6條生產線及配套中藥提取。預計新增年銷售金額約3億元人民幣。項目一期建成完全達產後,啟動項目二期建設。項目一期預計2021年4季度開工,建設期為36個月。

公吿稱,此次投資主要目的是引進先進的自動化生產線、利用禪方藥業的管理資源和藥品品種等資源,建設現代化高等級中成藥生產基地,提高中成藥生產能力和質量管控能力、擴大市場份額,為公司在醫療健康領域持續發展進一步夯實基礎。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account